Vivos (RDGL) Cash from Operations (2010 - 2025)
Vivos (RDGL) posted Cash from Operations of 539554.0 for Q4 2025, down 17.68% sequentially from 458481.0 in Q3 2025, and down 14.58% YoY from 631621.68 in Q4 2024.
Vivos (RDGL) Cash from Operations (2010 - 2025) Analysis & Trends
Vivos has reported Cash from Operations for 16 years, with the latest figure at 539554.0 in Q4 2025.
- Quarterly Cash from Operations fell 14.58% year-over-year to 539554.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2057743.0 (down 22.19% YoY) and the FY2025 annual result came in at 2057743.0, down 22.19% from the prior year.
- Cash from Operations retreated to 539554.0 in Q4 2025 per RDGL's latest filing, from 458481.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 171119.0 in Q2 2022 and troughed at 604510.0 in Q2 2025.
- A 5-year average of 355934.1 and a median of 349317.0 in 2021 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2022: Cash from Operations plunged 132.78% in 2021, then soared 50.71% in 2022.
- Over 5 years, Cash from Operations stood at 235468.0 in 2021, then decreased by 19.62% to 281667.0 in 2022, then slumped by 64.43% to 463137.0 in 2023, then decreased by 1.68% to 470912.0 in 2024, then declined by 14.58% to 539554.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 539554.0, 458481.0, and 604510.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | -539,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -539,554.00 |
| Dec 31, 2025 | -539,554.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | -455,198.00 |
| Mar 31, 2025 | -455,198.00 |
| Dec 31, 2024 | -470,912.00 |
| Dec 31, 2024 | -470,912.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | -355,412.00 |
| Jun 30, 2024 | -355,412.00 |
| Mar 31, 2024 | -351,458.00 |
| Mar 31, 2024 | -351,458.00 |
| Dec 31, 2023 | -463,137.00 |
| Dec 31, 2023 | -463,137.00 |
| Sep 30, 2023 | -221,923.00 |
| Sep 30, 2023 | -221,923.00 |